Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2025-12-25 @ 5:08 AM
NCT ID:
NCT03043027
Eligibility Criteria:
Inclusion Criteria:
1. Patients \>18 years old
2. Patients with calculus disease that can be treated with PCNL
Exclusion Criteria:
1. Patients \<18 years old.
2. Patients who are not able to give consent for study
3. Patients with active urinary tract infection
4. Pregnant women
5. Patients with hepatic insufficiency
6. Patients with more than 2 access tracts created
7. Allergies to bupivacaine or liposomal bupivacaine
8. Patients with chronic pain syndromes as determined by using \>30mg oral morphine equivalents per day
9. Patients who are neurologically impaired and may have altered pain sensation due to previous diseases (e.g. paraplegics, quadriplegics, systemic neurological condition, etc.)
10. Patients who are undergoing staged procedures during that same hospital stay
11. Patients who are placed on patient controlled analgesia or patient controlled epidural analgesia
12. Patients who remain intubated after surgery
13. Patients who will have ureteral stents
14. Patients who do not require care in the intensive care unit
15. Patients who are mentally impaired.
16. Patients who are criminal prisoners.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
100 Years
Study:
NCT03043027
Study Brief:
Protocol Section:
NCT03043027